DexCom, Inc.
DXCM
|
$131.5
0.6%
0.6%
2.1M
|
Health Technology
(0.0% 1d) (-6.1% 1m) (6.2% 1y) (0.0% 2d) (0.0% 3d) (0.6% 7d) (-26.2% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 50,695,277,862
http://www.dexcom.com
Sec Filling | Patents | 5200 employees
DexCom, Inc. is a medical device manufacturing company. The firm engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, DexCom G5 Mobil, DexCom Share and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
diabetes diabetic
add to watch list Paper trade email alert is off
Press-releases
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
|
| O: -1.17%
H: 1.22%
C: 0.23%
first conference
Wearable Healthcare Devices Market Worth $69.2 Billion | MarketsandMarkets™.
Published: 2024-02-19 (Crawled : 15:30) - prnewswire.com
AAPL | $165.91 0.55% 0.55% 48M
|
Electronic Technology
| Email alert
Add to watchlist
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
| Email alert
Add to watchlist
GRMN | $141.02 1.08% 0.0% 930K
|
Electronic Technology
| Email alert
Add to watchlist
IRTC | $113.74 1.47% 1.45% 300K
|
Health Technology
| Email alert
Add to watchlist
BSX | $68.02 1.03% 0.0% 7.6M
|
Health Technology
| Email alert
Add to watchlist
PHG | News | $20.61 3.15% 0.05% 1.6M
|
Health Technology
| Email alert
Add to watchlist
market
Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
Published: 2024-02-07 (Crawled : 12:30) - biospace.com/
PODD | $164.46 -1.08% -1.09% 680K
|
Health Technology
|
| O: -0.67%
H: 2.23%
C: 0.23%
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
|
| O: 0.0%
H: 1.77%
C: 1.35%
omnipod integration freestyle approval sensor libre plus
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
Published: 2024-01-31 (Crawled : 12:00) - globenewswire.com
TRIB | $1.8054 -3.87% 1.6K
|
Health Technology
|
| O: 15.22%
H: 25.72%
C: 17.74%
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
|
| O: 0.36%
H: 1.51%
C: 0.1%
biotech acquisition
Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
|
| O: -0.11%
H: 0.13%
C: -1.57%
conference year
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
Published: 2024-01-08 (Crawled : 14:00) - biospace.com/
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
|
| O: 1.4%
H: 3.67%
C: 3.12%
year revenue
Digital Diabetes Management Market Forecast Report 2023-2030, Featuring Key Players Medtronic, Abbott, Ascensia Diabetes Care, F. Hoffmann-La Roche, Bayer, LifeScan & Insulet
Published: 2023-12-21 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -0.12%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
PODD | $164.46 -1.08% -1.09% 680K
|
Health Technology
|
| O: -0.14%
H: 0.27%
C: -1.13%
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
|
| O: -0.34%
H: 0.19%
C: -0.17%
management report diabetes market
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-19 (Crawled : 14:00) - biospace.com/
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
|
| O: 0.23%
H: 0.77%
C: -0.28%
conference
United States Blood Glucose Monitoring Devices Market Report 2023-2028: New Products Significantly Impact the Demand for Devices - AI and IoT Advancements Fueling Growth
Published: 2023-12-13 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.06%
H: 2.36%
C: 2.36%
MDT | $80.57 1.37% 0.0% 5M
|
Health Technology
|
| O: -0.45%
H: 2.76%
C: 2.73%
BDX | $233.88 -0.1% 0.0% 770K
|
Health Technology
|
| O: -0.09%
H: 1.72%
C: 1.7%
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.27%
H: 2.28%
C: 2.16%
PODD | $164.46 -1.08% -1.09% 680K
|
Health Technology
|
| O: -0.28%
H: 4.22%
C: 4.11%
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
|
| O: -0.02%
H: 2.72%
C: 2.64%
report iot blood impact growth market
Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump
Published: 2023-12-06 (Crawled : 15:30) - biospace.com/
DXCM | $131.5 0.6% 0.6% 2.1M
|
Health Technology
|
| O: 0.46%
H: 1.12%
C: 0.17%
insulin
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Last 48 Hours Insiders Buying
MCFT P 26039 | $21.5 1.9% 1.86% 110K
|
Consumer Durables
|
00:00
YORW P 29 | $35.43 1.03% 1.02% 66K
|
Utilities
|
19:01
VUZI P 14500 | $1.35 11.57% 10.37% 890K
|
Electronic Technology
|
17:00
BANF P 256 | $91.28 2.24% 2.18% 150K
|
Finance
|
15:30
RMCF | $3.56 0.28% 0.28% 11K
|
Consumer Non-Durables
|
20:10